FAILED
首站-论文投稿智能助手
典型文献
Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
文献摘要:
Ebola virus(EBOV)infection leads to staggeringly high mortality rate.Effective and low-cost treatments are urgently needed to control frequent EBOV outbreaks in Africa.In this study,we report that a natural compound called berbamine hydrochloride strongly inhibits EBOV replication in vitro and in vivo.Our work further showed that berbamine hydrochloride acts by directly binding to the cleaved EBOV glyco-protein(GPcl),disrupting GPcl interaction with viral receptor Niemann-Pick Cl,thus blocking the fusion of viral and cellular membranes.Our data support the probability of developing anti-EBOV small molecule drugs by targeting viral GPcl.More importantly,since berbamine hydrochloride has been used in clinic to treat leukopenia,it holds great promise of being quickly repurposed as an anti-EBOV drug.
文献关键词:
作者姓名:
Dongrong Yi;Quanjie Li;Han Wang;Kai Lv;Ling Ma;Yujia Wang;Jing Wang;Yongxin Zhang;Mingliang Liu;Xiaoyu Li;Jianxun Qi;Yi Shi;George F.Gao;Shan Cen
作者机构:
Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical School,Beijing 100050,China;CAS Key Laboratory of Pathogenic Microbiology and Immunology,Institute of Microbiology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;CAMS Key Laboratory of Antiviral Drug Research,Institute of Medicinal Biotechnology,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100050,China
引用格式:
[1]Dongrong Yi;Quanjie Li;Han Wang;Kai Lv;Ling Ma;Yujia Wang;Jing Wang;Yongxin Zhang;Mingliang Liu;Xiaoyu Li;Jianxun Qi;Yi Shi;George F.Gao;Shan Cen-.Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein)[J].药学学报(英文版),2022(12):4378-4389
A类:
staggeringly,GPcl
B类:
Repurposing,berbamine,hydrochloride,Ebola,virus,by,targeting,viral,glycoprotein,EBOV,infection,leads,high,mortality,rate,Effective,low,cost,treatments,are,urgently,needed,control,frequent,outbreaks,Africa,In,this,study,report,that,natural,compound,called,strongly,inhibits,replication,vitro,vivo,Our,work,further,showed,acts,directly,binding,cleaved,disrupting,interaction,receptor,Niemann,Pick,Cl,thus,blocking,fusion,cellular,membranes,data,support,probability,developing,anti,small,molecule,drugs,More,importantly,since,has,been,used,clinic,leukopenia,holds,great,promise,being,quickly,repurposed
AB值:
0.599087
相似文献
Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
Xi Cheng;Wensi Zhao;Mengdi Zhu;Bo Wang;Xuege Wang;Xiaoyun Yang;Yuqi Huang;Minjia Tan;Jing Li-Department of Bioinformatics and Biostatistics,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;The Chemical Proteomics Center and State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Key Laboratory of Tissue Microenvironment and Tumor,Shanghai Institute of Nutrition and Health,Shanghai Institutes for Biological Sciences,University of Chinese Academy of Sciences,Chinese Academy of Sciences(CAS),Shanghai 200031,China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
In vitro investigation of HBV clinical isolates from Chinese patients reveals that genotype C isolates possess higher infectivity than genotype B isolates
Tingting Liu;Anlei Liu;Yong Liu;Shan Cen;Quan Zhang-Department of Transfusion Medicine,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing,210008,China;Department of Emergency Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Science,Beijing,100730,China;Department of Laboratory Medicine,Nanjing Drum Tower Hospital and Jiangsu Key Laboratory for Molecular Medicine,The Affiliated Hospital of Nanjing University Medical School,Nanjing,210008,China;Institute of Medicinal Biotechnology,Chinese Academy of Medical Science,Beijing,100050,China;Department of Infectious Diseases,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing,210008,China
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Peng-xuan Ren;Wei-juan Shang;Wan-chao Yin;Huan Ge;Lin Wang;Xiang-lei Zhang;Bing-qian Li;Hong-lin Li;Ye-chun Xu;Eric H.Xu;Hua-liang Jiang;Li-li Zhu;Lei-ke Zhang;Fang Bai-School of Life Science and Technology,and Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China;Department of Chemistry,Imperial College London,London,United Kingdom;University of Chinese Academy of Sciences,Beijing 100049,China
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang;Sui Fang;Yan Wu;Xi Cheng;Lei-ke Zhang;Xu-rui Shen;Shuang-qu Li;Jian-rong Xu;Wei-juan Shang;Zhao-bing Gao;Bing-qing Xia-CAS Key Laboratory of Receptor Research,Stake Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Pharmacology and Chemical Biology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang;Yan Wu;Sheng Yao;Huan Ge;Ya Zhu;Kun Chen;Wen-zhang Chen;Yi Zhang;Wei Zhu;Hong-yang Wang;Yu Guo;Pei-xiang Ma;Peng-xuan Ren;Xiang-lei Zhang;Hui-qiong Li;Mohammad A.Ali;Wen-qing Xu;Hua-liang Jiang;Lei-ke Zhang;Li-li Zhu;Yang Ye;Wei-juan Shang;Fang Bai-Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai 201210,China;School of Life Science and Technology,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430064,China;Department of Natural Products Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China;CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;College of Pharmacy and State Key Laboratory of Medicinal Chemical Biology,Nankai University,Tianjin 300071,China;Department of Botany and Microbiology,College of Science,King Saud University,Riyadh,Saudi Arabia
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。